Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

1600

Actual shortage: 198 (12%)
Anticipated shortage: 2 (0%)
Avoided shortage: 7 (0%)
Resolved: 1393 (87%)

Discontinuation Reports

235

To be discontinued: 3 (1%)
Discontinued: 232 (99%)
Reversed: 0 (0%)

Late reports

241 (13%)

Overdue reports

6 (3%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT AMLODIPINE 2.5MG TABLET Resolved 2017-03-17 2017-09-19 3348
ACT AMLODIPINE 5MG TABLET Resolved 2020-11-06 2021-01-07 127998
ACT AMLODIPINE 10MG TABLET Resolved 2020-11-06 2021-01-21 128034
ACT AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
ACT AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
ACT AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
ACT AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
ACT AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
ACT AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
ACT AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-03-11 131676
ACT AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-05-06 131679
ACT AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2021-03-25 2021-05-20 136286
ACT AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Avoided shortage 2021-05-20 2021-07-08 139722
ACT AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-15 2021-09-09 142610
TEVA-ANASTROZOLE 1MG TABLET Resolved 2020-01-24 2021-01-28 104374
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-01-30 2020-05-29 104930
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-09-25 2020-10-22 125031
TEVA-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Resolved 2019-09-26 2020-01-24 94896
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2019-10-03 2020-01-24 95396
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569

Showing 1 to 20 of 1600

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PREDNISONE 5MG TABLET Discontinued 2019-04-11 2019-04-11 81376
TEVA-PREGABALIN 75MG CAPSULE Discontinued 2020-07-10 2020-07-10 120033
TEVA-QUETIAPINE 100MG TABLET Discontinued 2018-10-19 2018-10-19 64846
TEVA-QUETIAPINE 25MG TABLET Discontinued 2018-10-19 2018-10-19 64849
TEVA-QUETIAPINE 100MG TABLET Discontinued 2018-10-19 2018-10-19 65036
TEVA-QUETIAPINE 200MG TABLET Discontinued 2018-10-19 2018-10-19 65039
TEVA-QUETIAPINE 25MG TABLET Discontinued 2018-10-19 2018-10-19 65044
TEVA-QUETIAPINE 300MG TABLET Discontinued 2018-10-19 2018-10-19 65047
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
TEVA-QUININE 200MG CAPSULE Discontinued 2020-10-08 2020-10-09 125976
TEVA-RABEPRAZOLE EC 20MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120015
TEVA-RABEPRAZOLE EC 10MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120018
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027

Showing 201 to 220 of 235